TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

BONTRIL PDM

PHENDIMETRAZINE TARTRATE
Metabolic Approved 1976-12-22
1
Indication
--
Phase 3 Trials
49
Years on Market

Details

Status
Prescription
First Approved
1976-12-22
Routes
ORAL
Dosage Forms
TABLET

Companies

Active Ingredient: PHENDIMETRAZINE TARTRATE

BONTRIL PDM Approval History

Loading approval history...

What BONTRIL PDM Treats

1 indications

BONTRIL PDM is approved for 1 conditions since its original approval in 1976. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Obesity
Source: FDA Label
πŸ”¬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
πŸ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

BONTRIL PDM FDA Label Details

Pro

Indications & Usage

Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follow: pounds Γ· 2.2 = kg; ...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.